THC

Tenet Healthcare Corp. 10-K Summary (Fiscal Year Ended Dec 31, 2003)

Business Context and Reporting Period

Tenet Healthcare Corporation is the second largest investor-owned health care services company in the United States. As of December 31, 2003, the company owned or operated 101 domestic general hospitals with 25,116 licensed beds across 15 states, with significant concentrations in California (33.3%), Florida (18.2%), and Texas (12.0%). The reporting period covers the fiscal year ended December 31, 2003, following a change from a May 31 fiscal year-end to a calendar year-end effective December 31, 2002.

Key Financial Metrics

Margin Analysis: Operating expenses (excluding impairment and restructuring) rose to 97.6% of net operating revenues in 2003, compared to 85.8% in 2002. The company recorded $1.881 billion in impairment and restructuring charges in 2003, primarily due to goodwill impairment ($1.124 billion) and long-lived asset write-downs ($646 million).

Material Changes vs. Prior Period

• Revenue Decline: Net operating revenues decreased 2.9% year-over-year. The primary driver was a $610 million reduction in Medicare outlier revenue, dropping from approximately $750 million in 2002 to $140 million in 2003 due to voluntary changes in calculation methods and new CMS regulations.
• Bad Debt Surge: The provision for doubtful accounts increased 48.7% to $1.441 billion, driven by an additional $198 million charge to reflect worsening collection trends for self-pay and managed care accounts.
• Restructuring: The company recorded $1.881 billion in impairment and restructuring charges in 2003, compared to $316 million in 2002. This included a $152 million charge for a contract damages award to a former executive.
• Divestitures: Tenet sold 11 hospitals and closed 2 in 2003. In January 2004, the company announced plans to divest an additional 27 hospitals to focus on a core portfolio of 69 facilities.

Guidance, Outlook, and Risks

Outlook: Management does not anticipate significant operating performance or margin improvement in 2004 or potentially 2005. Challenges include resolving government investigations, managing bad debt from uninsured patients, and the negative cash flow impact of hospitals held for sale. The company expects to receive approximately $600 million in net proceeds from the proposed 2004 divestitures, largely in the form of tax benefits.

Material Risks and Contingencies:

• Legal Proceedings: The company faces extensive federal and state investigations regarding physician relationships, Medicare outlier payments, and billing practices. Notable matters include a $54 million settlement regarding Redding Medical Center and a $163.3 million payment to a former executive (John C. Bedrosian) in March 2004.
• Regulatory: Changes in Medicare reimbursement rules and state-mandated nurse-staffing ratios (effective Jan 1, 2004, in California) are expected to increase labor costs and limit patient admissions.
• Liquidity: While the company had approximately $600 million in unrestricted cash at year-end, it amended its credit agreement in March 2004 to relax leverage covenants due to anticipated performance declines.

Investor Verification Checklist

• Verify the final settlement terms and potential future liabilities related to the Redding Medical Center and other Medicare outlier investigations.
• Monitor the progress and net proceeds of the announced divestiture of 27 hospitals scheduled for 2004.
• Assess the impact of the new "Compact with Uninsured Patients" discount plan on future bad debt expense versus net revenue.
• Review the status of the $157 million proposed IRS tax deficiency assessment for fiscal years 1995-1997.
• Track the company's ability to comply with amended credit agreement covenants, specifically the leverage ratio and fixed charge coverage.